HEADER IMMUNE SYSTEM 11-MAY-11 3RY6 TITLE COMPLEX OF FCGAMMARIIA (CD32) AND THE FC OF HUMAN IGG1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: IG GAMMA-1 CHAIN C REGION; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 114-327; COMPND 5 SYNONYM: FC OF HUMAN IGG1, HEAVY CHAIN; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: LOW AFFINITY IMMUNOGLOBULIN GAMMA FC REGION RECEPTOR II-A; COMPND 9 CHAIN: C; COMPND 10 FRAGMENT: UNP RESIDUES 40-206; COMPND 11 SYNONYM: IGG FC RECEPTOR II-A, CDW32, FC-GAMMA RII-A, FC-GAMMA-RIIA, COMPND 12 FCRII-A; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IGHG1; SOURCE 6 EXPRESSION_SYSTEM: MUS MUSCULUS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: MOUSE; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 10090; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: NS0 MURINE MYELOMA CELLS; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 GENE: CD32, FCG2, FCGR2A, FCGR2A1, IGFR2; SOURCE 15 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 16 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 18 EXPRESSION_SYSTEM_CELL_LINE: SF21; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PVL1392 KEYWDS FC RECEPTOR, CD32, IMMUNOGLOBULIN SUPERFAMILY, HIGH RESPONDER KEYWDS 2 POLYMORPHISM, HUMAN IGG1, THERAPEUTIC ANTIBODY, GLYCOPROTEIN, KEYWDS 3 IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, CELL MEMBRANE, IGG- KEYWDS 4 BINDING PROTEIN, MEMBRANE, PHOSPHOPROTEIN, RECEPTOR, TRANSMEMBRANE, KEYWDS 5 IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR P.A.RAMSLAND,W.FARRUGIA,A.M.SCOTT,P.M.HOGARTH REVDAT 5 06-NOV-24 3RY6 1 REMARK REVDAT 4 13-SEP-23 3RY6 1 HETSYN REVDAT 3 29-JUL-20 3RY6 1 COMPND REMARK SEQADV HETNAM REVDAT 3 2 1 LINK SITE ATOM REVDAT 2 21-SEP-11 3RY6 1 JRNL REVDAT 1 31-AUG-11 3RY6 0 JRNL AUTH P.A.RAMSLAND,W.FARRUGIA,T.M.BRADFORD,C.T.SARDJONO,S.ESPARON, JRNL AUTH 2 H.M.TRIST,M.S.POWELL,P.S.TAN,A.C.CENDRON,B.D.WINES, JRNL AUTH 3 A.M.SCOTT,P.M.HOGARTH JRNL TITL STRUCTURAL BASIS FOR FC{GAMMA}RIIA RECOGNITION OF HUMAN IGG JRNL TITL 2 AND FORMATION OF INFLAMMATORY SIGNALING COMPLEXES. JRNL REF J.IMMUNOL. V. 187 3208 2011 JRNL REFN ISSN 0022-1767 JRNL PMID 21856937 JRNL DOI 10.4049/JIMMUNOL.1101467 REMARK 2 REMARK 2 RESOLUTION. 3.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.71 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 11110 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.252 REMARK 3 FREE R VALUE : 0.426 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1147 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.94 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2770 REMARK 3 BIN FREE R VALUE : 0.5800 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 112 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.055 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4745 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 400 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 134.6 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.44 REMARK 3 ESD FROM SIGMAA (A) : 0.52 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.93 REMARK 3 ESD FROM C-V SIGMAA (A) : 1.59 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : 1.800 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.370 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3RY6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-MAY-11. REMARK 100 THE DEPOSITION ID IS D_1000065522. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-APR-04 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.40 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC BLUE MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11766 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.800 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.13700 REMARK 200 FOR THE DATA SET : 10.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.94 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.35000 REMARK 200 FOR SHELL : 3.780 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1E4K REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 71.04 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% (W/V) PEG 3350, 5MM TRIS, 0.15M REMARK 280 NACL, 2MM MOPS, 0.2M TRI-POTASSIUM ACETATE, PH 7.40, VAPOR REMARK 280 DIFFUSION, TEMPERATURE 291.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 29.22000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 29.22000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 76.69000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 127.77500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 76.69000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 127.77500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 29.22000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 76.69000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 127.77500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 29.22000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 76.69000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 127.77500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN A 297 C1 NDG D 1 1.45 REMARK 500 ND2 ASN C 145 C1 NDG F 1 1.46 REMARK 500 O PHE B 241 O VAL B 262 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O SER C 77 O SER C 77 4557 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 291 C - N - CD ANGL. DEV. = -13.5 DEGREES REMARK 500 PRO A 346 C - N - CA ANGL. DEV. = 13.1 DEGREES REMARK 500 CYS A 425 CA - CB - SG ANGL. DEV. = 6.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 232 -144.73 -89.39 REMARK 500 GLU A 233 81.47 91.33 REMARK 500 LEU A 234 -125.01 -60.49 REMARK 500 LEU A 235 134.73 82.56 REMARK 500 PRO A 238 101.59 -52.06 REMARK 500 PHE A 241 159.78 174.29 REMARK 500 PRO A 245 150.09 -45.93 REMARK 500 THR A 260 -159.44 -76.15 REMARK 500 CYS A 261 71.85 -176.81 REMARK 500 VAL A 263 40.69 -156.19 REMARK 500 VAL A 264 164.56 -49.95 REMARK 500 ASP A 265 104.04 72.91 REMARK 500 HIS A 268 19.98 -55.17 REMARK 500 ASP A 270 56.00 -171.96 REMARK 500 PRO A 271 85.45 -64.35 REMARK 500 GLN A 272 43.77 -99.59 REMARK 500 VAL A 273 99.49 -50.47 REMARK 500 LYS A 274 -165.49 -70.58 REMARK 500 PHE A 275 127.88 -177.09 REMARK 500 TYR A 278 -71.40 -24.55 REMARK 500 VAL A 279 89.92 63.65 REMARK 500 VAL A 282 -115.05 -60.19 REMARK 500 GLN A 283 102.07 -47.28 REMARK 500 VAL A 284 -19.52 -47.50 REMARK 500 HIS A 285 -78.64 146.35 REMARK 500 ASN A 286 -91.31 54.30 REMARK 500 ALA A 287 -155.25 -133.79 REMARK 500 LYS A 288 -7.06 74.98 REMARK 500 PRO A 291 -155.94 -131.49 REMARK 500 ARG A 292 148.52 159.42 REMARK 500 GLN A 294 -172.59 -172.84 REMARK 500 TYR A 296 -78.11 -149.34 REMARK 500 SER A 298 -15.13 171.91 REMARK 500 TYR A 300 -170.90 -52.01 REMARK 500 THR A 307 110.86 -12.05 REMARK 500 HIS A 310 -70.92 -53.37 REMARK 500 ASN A 312 58.54 -102.39 REMARK 500 TRP A 313 -5.61 -144.01 REMARK 500 LEU A 314 -164.69 -122.52 REMARK 500 ASP A 315 -80.92 54.01 REMARK 500 SER A 324 -157.11 -100.68 REMARK 500 ASN A 325 157.07 148.95 REMARK 500 ALA A 327 2.21 -68.25 REMARK 500 PRO A 331 -156.44 -55.00 REMARK 500 ILE A 332 75.75 -153.57 REMARK 500 GLU A 333 105.85 -49.70 REMARK 500 THR A 335 164.22 -47.17 REMARK 500 ILE A 336 125.75 172.43 REMARK 500 LYS A 338 136.61 -31.97 REMARK 500 LYS A 340 -133.00 -59.61 REMARK 500 REMARK 500 THIS ENTRY HAS 223 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 NDG D 1 REMARK 610 NDG F 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3RY4 RELATED DB: PDB REMARK 900 RELATED ID: 3RY5 RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THERE ARE VARIANT D239E (VAR_002887), VARIANT L241M (VAR_003888) IN REMARK 999 G1M(NON-1) MARKER. EU DIFFERS IN THE AMIDATION STATES OF RESIDUES REMARK 999 155, 166, 177, 195, 198 IN REFERENCE: BIOCHEMISTRY 20 (9), 2361- REMARK 999 2370 (1981) PUBMED 7236608, AUTHOR DEISENHOFER,J., TITLE REMARK 999 CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC REMARK 999 FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM REMARK 999 STAPHYLOCOCCUS AUREUS AT 2.9- AND 2.8-A RESOLUTION. DBREF 3RY6 A 231 444 UNP P01857 IGHG1_HUMAN 114 327 DBREF 3RY6 B 231 444 UNP P01857 IGHG1_HUMAN 114 327 DBREF 3RY6 C 7 173 UNP P12318 FCG2A_HUMAN 40 206 SEQADV 3RY6 GLN A 272 UNP P01857 GLU 155 SEE REMARK 999 SEQADV 3RY6 GLN A 283 UNP P01857 GLU 166 SEE REMARK 999 SEQADV 3RY6 GLN A 294 UNP P01857 GLU 177 SEE REMARK 999 SEQADV 3RY6 ASN A 312 UNP P01857 ASP 195 SEE REMARK 999 SEQADV 3RY6 ASP A 315 UNP P01857 ASN 198 SEE REMARK 999 SEQADV 3RY6 GLU A 356 UNP P01857 ASP 239 VARIANT SEQADV 3RY6 MET A 358 UNP P01857 LEU 241 VARIANT SEQADV 3RY6 GLN B 272 UNP P01857 GLU 155 SEE REMARK 999 SEQADV 3RY6 GLN B 283 UNP P01857 GLU 166 SEE REMARK 999 SEQADV 3RY6 GLN B 294 UNP P01857 GLU 177 SEE REMARK 999 SEQADV 3RY6 ASN B 312 UNP P01857 ASP 195 SEE REMARK 999 SEQADV 3RY6 ASP B 315 UNP P01857 ASN 198 SEE REMARK 999 SEQADV 3RY6 GLU B 356 UNP P01857 ASP 239 VARIANT SEQADV 3RY6 MET B 358 UNP P01857 LEU 241 VARIANT SEQADV 3RY6 ARG C 134 UNP P12318 HIS 167 ENGINEERED MUTATION SEQRES 1 A 214 ALA PRO GLU LEU LEU GLY GLY PRO SER VAL PHE LEU PHE SEQRES 2 A 214 PRO PRO LYS PRO LYS ASP THR LEU MET ILE SER ARG THR SEQRES 3 A 214 PRO GLU VAL THR CYS VAL VAL VAL ASP VAL SER HIS GLU SEQRES 4 A 214 ASP PRO GLN VAL LYS PHE ASN TRP TYR VAL ASP GLY VAL SEQRES 5 A 214 GLN VAL HIS ASN ALA LYS THR LYS PRO ARG GLU GLN GLN SEQRES 6 A 214 TYR ASN SER THR TYR ARG VAL VAL SER VAL LEU THR VAL SEQRES 7 A 214 LEU HIS GLN ASN TRP LEU ASP GLY LYS GLU TYR LYS CYS SEQRES 8 A 214 LYS VAL SER ASN LYS ALA LEU PRO ALA PRO ILE GLU LYS SEQRES 9 A 214 THR ILE SER LYS ALA LYS GLY GLN PRO ARG GLU PRO GLN SEQRES 10 A 214 VAL TYR THR LEU PRO PRO SER ARG GLU GLU MET THR LYS SEQRES 11 A 214 ASN GLN VAL SER LEU THR CYS LEU VAL LYS GLY PHE TYR SEQRES 12 A 214 PRO SER ASP ILE ALA VAL GLU TRP GLU SER ASN GLY GLN SEQRES 13 A 214 PRO GLU ASN ASN TYR LYS THR THR PRO PRO VAL LEU ASP SEQRES 14 A 214 SER ASP GLY SER PHE PHE LEU TYR SER LYS LEU THR VAL SEQRES 15 A 214 ASP LYS SER ARG TRP GLN GLN GLY ASN VAL PHE SER CYS SEQRES 16 A 214 SER VAL MET HIS GLU ALA LEU HIS ASN HIS TYR THR GLN SEQRES 17 A 214 LYS SER LEU SER LEU SER SEQRES 1 B 214 ALA PRO GLU LEU LEU GLY GLY PRO SER VAL PHE LEU PHE SEQRES 2 B 214 PRO PRO LYS PRO LYS ASP THR LEU MET ILE SER ARG THR SEQRES 3 B 214 PRO GLU VAL THR CYS VAL VAL VAL ASP VAL SER HIS GLU SEQRES 4 B 214 ASP PRO GLN VAL LYS PHE ASN TRP TYR VAL ASP GLY VAL SEQRES 5 B 214 GLN VAL HIS ASN ALA LYS THR LYS PRO ARG GLU GLN GLN SEQRES 6 B 214 TYR ASN SER THR TYR ARG VAL VAL SER VAL LEU THR VAL SEQRES 7 B 214 LEU HIS GLN ASN TRP LEU ASP GLY LYS GLU TYR LYS CYS SEQRES 8 B 214 LYS VAL SER ASN LYS ALA LEU PRO ALA PRO ILE GLU LYS SEQRES 9 B 214 THR ILE SER LYS ALA LYS GLY GLN PRO ARG GLU PRO GLN SEQRES 10 B 214 VAL TYR THR LEU PRO PRO SER ARG GLU GLU MET THR LYS SEQRES 11 B 214 ASN GLN VAL SER LEU THR CYS LEU VAL LYS GLY PHE TYR SEQRES 12 B 214 PRO SER ASP ILE ALA VAL GLU TRP GLU SER ASN GLY GLN SEQRES 13 B 214 PRO GLU ASN ASN TYR LYS THR THR PRO PRO VAL LEU ASP SEQRES 14 B 214 SER ASP GLY SER PHE PHE LEU TYR SER LYS LEU THR VAL SEQRES 15 B 214 ASP LYS SER ARG TRP GLN GLN GLY ASN VAL PHE SER CYS SEQRES 16 B 214 SER VAL MET HIS GLU ALA LEU HIS ASN HIS TYR THR GLN SEQRES 17 B 214 LYS SER LEU SER LEU SER SEQRES 1 C 167 LYS ALA VAL LEU LYS LEU GLU PRO PRO TRP ILE ASN VAL SEQRES 2 C 167 LEU GLN GLU ASP SER VAL THR LEU THR CYS GLN GLY ALA SEQRES 3 C 167 ARG SER PRO GLU SER ASP SER ILE GLN TRP PHE HIS ASN SEQRES 4 C 167 GLY ASN LEU ILE PRO THR HIS THR GLN PRO SER TYR ARG SEQRES 5 C 167 PHE LYS ALA ASN ASN ASN ASP SER GLY GLU TYR THR CYS SEQRES 6 C 167 GLN THR GLY GLN THR SER LEU SER ASP PRO VAL HIS LEU SEQRES 7 C 167 THR VAL LEU SER GLU TRP LEU VAL LEU GLN THR PRO HIS SEQRES 8 C 167 LEU GLU PHE GLN GLU GLY GLU THR ILE MET LEU ARG CYS SEQRES 9 C 167 HIS SER TRP LYS ASP LYS PRO LEU VAL LYS VAL THR PHE SEQRES 10 C 167 PHE GLN ASN GLY LYS SER GLN LYS PHE SER ARG LEU ASP SEQRES 11 C 167 PRO THR PHE SER ILE PRO GLN ALA ASN HIS SER HIS SER SEQRES 12 C 167 GLY ASP TYR HIS CYS THR GLY ASN ILE GLY TYR THR LEU SEQRES 13 C 167 PHE SER SER LYS PRO VAL THR ILE THR VAL GLN MODRES 3RY6 ASN B 297 ASN GLYCOSYLATION SITE MODRES 3RY6 ASN C 64 ASN GLYCOSYLATION SITE HET NDG D 1 14 HET NAG D 2 14 HET BMA D 3 11 HET MAN D 4 11 HET NAG D 5 14 HET GAL D 6 11 HET SIA D 7 20 HET MAN D 8 11 HET NAG D 9 14 HET FUL D 10 10 HET NAG E 1 14 HET NAG E 2 14 HET BMA E 3 11 HET MAN E 4 11 HET NAG E 5 14 HET GAL E 6 11 HET SIA E 7 20 HET MAN E 8 11 HET NAG E 9 14 HET GAL E 10 11 HET SIA E 11 20 HET FUL E 12 10 HET NDG F 1 14 HET NAG F 2 14 HET MAN F 3 11 HET BMA F 4 11 HET MAN F 5 11 HET FUL F 6 10 HET GOL A 600 6 HET GOL B 601 6 HET GOL B 602 6 HET GOL B 603 6 HET NAG C 206 14 HETNAM NDG 2-ACETAMIDO-2-DEOXY-ALPHA-D-GLUCOPYRANOSE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE HETNAM SIA N-ACETYL-ALPHA-NEURAMINIC ACID HETNAM FUL BETA-L-FUCOPYRANOSE HETNAM GOL GLYCEROL HETSYN NDG N-ACETYL-ALPHA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY- HETSYN 2 NDG ALPHA-D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2- HETSYN 3 NDG ACETAMIDO-2-DEOXY-GLUCOSE; 2-(ACETYLAMINO)-2-DEOXY-A- HETSYN 4 NDG D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN GAL BETA-D-GALACTOSE; D-GALACTOSE; GALACTOSE HETSYN SIA N-ACETYLNEURAMINIC ACID; SIALIC ACID; ALPHA-SIALIC HETSYN 2 SIA ACID; O-SIALIC ACID HETSYN FUL BETA-L-FUCOSE; 6-DEOXY-BETA-L-GALACTOPYRANOSE; L- HETSYN 2 FUL FUCOSE; FUCOSE; 6-DEOXY-BETA-L-GALACTOSE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 4 NDG 2(C8 H15 N O6) FORMUL 4 NAG 9(C8 H15 N O6) FORMUL 4 BMA 3(C6 H12 O6) FORMUL 4 MAN 6(C6 H12 O6) FORMUL 4 GAL 3(C6 H12 O6) FORMUL 4 SIA 3(C11 H19 N O9) FORMUL 4 FUL 3(C6 H12 O5) FORMUL 7 GOL 4(C3 H8 O3) HELIX 1 1 PRO A 247 LEU A 251 5 5 HELIX 2 2 SER A 354 THR A 359 1 6 HELIX 3 3 LYS A 414 GLY A 420 1 7 HELIX 4 4 SER C 112 LYS C 116 5 5 SHEET 1 A 4 GLN A 347 VAL A 348 0 SHEET 2 A 4 GLN A 362 LYS A 370 -1 O LYS A 370 N GLN A 347 SHEET 3 A 4 PHE A 405 ASP A 413 -1 O LEU A 410 N LEU A 365 SHEET 4 A 4 TYR A 391 LYS A 392 -1 N LYS A 392 O LYS A 409 SHEET 1 B 2 VAL A 379 GLU A 382 0 SHEET 2 B 2 SER A 424 VAL A 427 -1 O SER A 426 N GLU A 380 SHEET 1 C 3 VAL B 348 TYR B 349 0 SHEET 2 C 3 LEU B 368 PHE B 372 -1 O LEU B 368 N TYR B 349 SHEET 3 C 3 PHE B 404 LEU B 406 -1 O PHE B 404 N PHE B 372 SHEET 1 D 3 VAL B 379 TRP B 381 0 SHEET 2 D 3 CYS B 425 VAL B 427 -1 O SER B 426 N GLU B 380 SHEET 3 D 3 THR B 437 GLN B 438 -1 O THR B 437 N VAL B 427 SHEET 1 E 2 LYS B 392 THR B 393 0 SHEET 2 E 2 SER B 408 LYS B 409 -1 O LYS B 409 N LYS B 392 SHEET 1 F 2 MET C 107 ARG C 109 0 SHEET 2 F 2 THR C 138 SER C 140 -1 O PHE C 139 N LEU C 108 SHEET 1 G 3 LEU C 118 VAL C 119 0 SHEET 2 G 3 ASN C 157 ILE C 158 -1 O ASN C 157 N VAL C 119 SHEET 3 G 3 THR C 161 LEU C 162 -1 O THR C 161 N ILE C 158 SHEET 1 H 2 PHE C 123 PHE C 124 0 SHEET 2 H 2 HIS C 153 CYS C 154 -1 O HIS C 153 N PHE C 124 SSBOND 1 CYS A 261 CYS A 321 1555 1555 2.03 SSBOND 2 CYS A 367 CYS A 425 1555 1555 2.05 SSBOND 3 CYS B 261 CYS B 321 1555 1555 2.04 SSBOND 4 CYS B 367 CYS B 425 1555 1555 2.03 SSBOND 5 CYS C 29 CYS C 71 1555 1555 2.04 SSBOND 6 CYS C 110 CYS C 154 1555 1555 2.03 LINK ND2 ASN B 297 C1 NAG E 1 1555 1555 1.45 LINK ND2 ASN C 64 C1 NAG C 206 1555 1555 1.46 LINK O4 NDG D 1 C1 NAG D 2 1555 1555 1.39 LINK O6 NDG D 1 C1 FUL D 10 1555 1555 1.41 LINK O4 NAG D 2 C1 BMA D 3 1555 1555 1.38 LINK O3 BMA D 3 C1 MAN D 4 1555 1555 1.41 LINK O6 BMA D 3 C1 MAN D 8 1555 1555 1.41 LINK O2 MAN D 4 C1 NAG D 5 1555 1555 1.40 LINK O4 NAG D 5 C1 GAL D 6 1555 1555 1.40 LINK O6 GAL D 6 C2 SIA D 7 1555 1555 1.40 LINK O2 MAN D 8 C1 NAG D 9 1555 1555 1.40 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.39 LINK O6 NAG E 1 C1 FUL E 12 1555 1555 1.40 LINK O4 NAG E 2 C1 BMA E 3 1555 1555 1.39 LINK O3 BMA E 3 C1 MAN E 4 1555 1555 1.41 LINK O6 BMA E 3 C1 MAN E 8 1555 1555 1.40 LINK O2 MAN E 4 C1 NAG E 5 1555 1555 1.39 LINK O4 NAG E 5 C1 GAL E 6 1555 1555 1.39 LINK O6 GAL E 6 C2 SIA E 7 1555 1555 1.41 LINK O2 MAN E 8 C1 NAG E 9 1555 1555 1.38 LINK O4 NAG E 9 C1 GAL E 10 1555 1555 1.40 LINK O6 GAL E 10 C2 SIA E 11 1555 1555 1.41 LINK O4 NDG F 1 C1 NAG F 2 1555 1555 1.40 LINK O6 NDG F 1 C1 FUL F 6 1555 1555 1.42 LINK O4 NAG F 2 C1 MAN F 3 1555 1555 1.40 LINK O3 MAN F 3 C1 BMA F 4 1555 1555 1.40 LINK O6 MAN F 3 C1 MAN F 5 1555 1555 1.40 CISPEP 1 TYR B 373 PRO B 374 0 0.23 CRYST1 153.380 255.550 58.440 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006520 0.000000 0.000000 0.00000 SCALE2 0.000000 0.003913 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017112 0.00000